Frontlight ResearchEarly access
Liver and biliary tract cancer trials in France
107 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Besancon Cedex, Bordeaux, Caen Cedex 5, Clermont Ferrand Cedex1, Marseille, Nice Cedex 2, Paris, Rennes Cedex, Saint-Herblain, Strasbourg Cedex 2, Vandoeuvre Les Nancy_ Cedex, Villejuif
- Age
- 18 years and over
- People
- 1,394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - Phase 3Taking peopleA Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
- Where
- Clichy, Grenoble Cedex 9, Marseille, Vandouvre Les Nancy
- Age
- 18 years and over
- People
- 1,100 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07221253 · EU 2025-523085-24-00 - Phase 2Taking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Bordeaux, Lyon, Suresnes
- Age
- 18 years to 130 years
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - Phase 1/2Taking peopleA Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
- Where
- Clichy, Nantes, Villejuif
- Age
- 18 years and over
- People
- 630 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT06427941 · EU 2025-524136-19-00 - Phase 1/2Taking peopleSafety of HRX215 in Patients After Minor and Major Liver Resection
- Where
- Lille, Villejuif
- Age
- 18 years to 75 years
- People
- 80 worldwide
- Run by
- HepaRegeniX GmbH
See details and how to joinNCT06638502 - No phaseTaking peopleAcupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients
- Where
- Amiens, Caen, Créteil, Grenoble, Lille, Nîmes, Paris, Saint-Cloud, Saint-Mandé, Villejuif
- Age
- 18 years and over
- People
- 182
- Run by
- GERCOR - Multidisciplinary Oncology Cooperative Group
See details and how to joinNCT05850130 - Phase 2Taking peopleMICROBIOTA MODIFICATION FOR IMMUNO-ONCOLOGY IN HEPATOCELLULAR CARCINOMA - “MOTHER”
- Where
- Bobigny Cedex, Clichy, Nantes, Pessac, Rennes Cedex, Villejuif
- Age
- 18 years and over
- People
- 80
- Run by
- Centre De Lutte Contre Le Cancer Eugene Marquis
See details and how to join2023-508201-25-00 - Phase 1/2Taking peopleSafety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- Where
- Brest, Lyon, Saint-Herblain, Villejuif
- Age
- 18 years and over
- People
- 225 worldwide
- Run by
- Tango Therapeutics, Inc.
See details and how to joinNCT05732831 - Phase 1/2Taking people[68Ga]Ga-PSMA PET/CT in Hepatocellular Carcinoma: Impact of Multiparametric Dynamic Whole-body Imaging and Kinetic Modeling.
- Where
- Clichy, Nantes Cedex 1
- Age
- 18 years and over
- People
- 40
- Run by
- Nantes University Hospital
See details and how to joinNCT06999837 · EU 2024-515178-28-00 - No phaseNot yet taking people in FranceRegistry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance
- Where
- Créteil, Lyon
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Mark C Burgmans, MD PhD
See details and how to joinNCT07636148 - Phase 2Taking peopleTesting Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients
- Where
- Amiens Cedex 1, Angers, Avignon Cedex 9, Besancon Cedex, Caen Cedex 5, Clermont-Ferrand, Clermont Ferrand Cedex1, Clichy, Creteil Cedex, Dijon, Grenoble, Grenoble Cedex 9, Lille, Lille Cedex, Limoges, Lyon, Marseille, Montpellier Cedex 5, Nantes, Nantes Cedex 2, Nice Cedex 2, Paris, Pau Cedex, Pessac Cedex, Poitiers, Quimper Cedex, Reims, Reims Cedex, Rennes Cedex, Rouen Cedex, Saint-Cloud, Saint-Herblain Cedex, Suresnes, Toulouse Cedex 9, Valence, Vandoeuvre Les Nancy, Villejuif
- Age
- 18 years and over
- People
- 72 worldwide
- Run by
- UNICANCER
See details and how to joinNCT06529718 · EU 2024-515875-36-00 - Phase 3Taking peopleA Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician’s Choice in Subjects with Fibroblast Growth Factor Receptor (FGFR) altered, Chemotherapy- and FGFR Inhibitor-Refractory/Relapsed Cholangiocarcinoma (FIRST-308)
- Where
- Avignon Cedex 9, Besancon Cedex, Clichy, Levallois-Perret, Lyon, Paris Cedex 12, Villejuif
- Age
- 18 years and over
- People
- 126 worldwide
- Run by
- Transthera Sciences (Nanjing) Inc.
See details and how to join2023-505660-11-00 - Phase 2Taking peopleFAPI-PET value for the initial screening of pancreatic and biliary cancers (FAPDIG Study)
- Where
- Lyon, Montpellier Cedex 5, Talence
- Age
- 18 years and over
- People
- 120
- Run by
- Centre Hospitalier Universitaire De Bordeaux
See details and how to join2024-517270-23-00 - Phase 2Taking peopleTERTIO : Evaluation de l’intérêt de combiner un vaccin inducteur de CD4-Th1 dérivé de la télomérase avec un traitement par atezolizumab et bevacizumab chez des patients avec un carcinome hépatocellulaire non résécable : une étude de phase II randomisée preuve du concept
- Where
- Angers, Besancon Cedex, Chalon Sur Saone, Clichy, Creteil Cedex, Dijon, Grenoble Cedex 9, Lyon, Montpellier Cedex 5, Mulhouse, Paris, Paris Cedex 13, Poitiers, Trévenans
- Age
- 18 years and over
- People
- 104
- Run by
- CHUR Of Besançon
See details and how to join2022-500643-20-00 - No phaseTaking peopleTARGETed Therapy Drug MONITOring in DIGestive Oncology
- Where
- Amiens, Auxerre, Avignon, Bayeux, Clermont-Ferrand, Clichy, Dijon, Évreux, Lille, Lyon, Marseille, Nancy, Nantes, Nice, Paris, Plérin, Poitiers, Reims, Rennes, Rouen, St-Malo, Strasbourg, Tours, Villejuif
- Age
- 18 years and over
- People
- 330
- Run by
- UNICANCER
See details and how to joinNCT05443087 - Phase 2Taking peopleA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- Angers, Bordeaux, Brest, Marseille, Paris Cedex 13, Toulouse Cedex 9, Villejuif
- Age
- 8 years and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00 - No phaseTaking peopleIdentification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Durvalumab
- Where
- Besançon, Chalon-sur-Saône, Grenoble, Mulhouse, Paris, Poitiers, Reims, Strasbourg
- Age
- 18 years and over
- People
- 120
- Run by
- Centre Hospitalier Universitaire de Besancon
See details and how to joinNCT06796114 - Phase 1Taking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Bordeaux, Paris, Villejuif
- Age
- 18 years and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - No phaseTaking peopleOutpatient Versus Inpatient Care Pathway for Intra-arterial Treatment of Primary Liver Cancer (CHOC)
- Where
- Amiens, Angers, Besançon, Bobigny, Brest, Clichy, La Roche-sur-Yon, La Tronche, Marseille, Montpellier, Nantes, Nice, Paris, Pessac, Toulouse, Villejuif
- Age
- 18 years and over
- People
- 206
- Run by
- University Hospital, Angers
See details and how to joinNCT06990659 - Phase 1/2Taking peopleA Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- Where
- Dijon, Marseille, Toulouse, Villejuif
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Alentis Therapeutics AG
See details and how to joinNCT07169734 · EU 2025-521441-24-00 - Phase 1/2Not yet taking people in FranceExploratory study of the performance of dynamic PET-CT acquisition to predict 6-month morphological response in patients with hepatocellular carcinoma treated with selective internal radiotherapy
- Where
- Dijon
- Age
- 18 years and over
- People
- 30
- Run by
- Centr Georges Francois Leclerc
See details and how to join2026-526324-48-00 - No phaseTaking peopleEvaluation of Skin Tests in Biotherapy Allergies
- Where
- Angers
- Age
- 18 years and over
- People
- 70
- Run by
- University Hospital, Angers
See details and how to joinNCT06971848 - No phaseTaking peoplemSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis
- Where
- Vandœuvre-lès-Nancy
- Age
- 18 years and over
- People
- 400
- Run by
- Central Hospital, Nancy, France
See details and how to joinNCT06778317 - No phaseTaking peopleProspEXPO : Study of the Associations Between Hepatocellular Carcinoma and Chemical and Psychosocial Environmental EXPOsome
- Where
- Angers, Rennes, Tours
- Age
- 18 years and over
- People
- 300
- Run by
- University Hospital, Angers
See details and how to joinNCT07119957 - Phase 1Taking peopleIs CT 01 safe to use alone or combined with Everolimus for inoperable advanced liver cancer?
- Where
- Bobigny, Dijon, Lyon, Nantes, Poitiers, Strasbourg Cedex, Toulouse, Villejuif
- Age
- 18 years and over
- People
- 154 worldwide
- Run by
- Captor Therapeutics S.A.
See details and how to join2024-511435-10-00